XML 57 R44.htm IDEA: XBRL DOCUMENT v3.21.1

Equity Awards and Instruments (Tables)

3 Months Ended

Mar. 31, 2021

Share-based Payment Arrangement [Abstract]

Schedule of Stock-based Compensation Expense

Total stock‑based compensation expense was as follows:

			Three Months Ended
			March 31,
			2021						2020
Stock option expense			$	998					$	1,534
Restricted stock and restricted stock units (“RSUs”) expense			1,497						—
Stock grants expense			—						119
Bonus Plan expense (see Note 11)			6,124						—
ESPP expense (see Note 13)			449						—
Total pre-tax expense (1)			$	9,068					$	1,653

(1)As of March 31, 2021 and December 31, 2020, $6,279 and $6,835 remained in Accruals and other current liabilities in the consolidated balance sheets, respectively.

Total stock‑based compensation expense is included in the consolidated statements of operations as follows:

			Three Months Ended
			March 31,
			2021						2020
Cost of subscriptions and licenses			$	89					$	28
Cost of services			243						96
Research and development			3,955						619
Selling and marketing			788						400
General and administrative			3,993						510
Total pre-tax expense			$	9,068					$	1,653

Schedule of Options

The following is a summary of stock option activity and related information under the Company’s applicable equity incentive plans:

															Weighted
									Weighted						Average
									Average						Remaining						Aggregate
			Stock						Exercise Price						Contractual						Intrinsic
			Options						Per Share						Life (in years)						Value
Outstanding, December 31, 2020			12,842,226						$	4.87
Exercised			(1,525,331)						4.23
Canceled			(45,250)						5.12
Outstanding, March 31, 2021			11,271,645						$	4.96					1.93						$	473,067
Exercisable, March 31, 2021			6,859,645						$	4.60					1.52						$	290,383

Schedule of Restricted Stock and Restricted Stock Unit Activity

The following is a summary of unvested restricted stock and RSU activity and related information under the Company’s applicable equity incentive plans:

																					Time-						Performance-
																					Based						Based
									Time-						Performance-						Weighted						Weighted
			Total						Based						Based						Average						Average
			Restricted						Restricted						Restricted						Grant Date						Grant Date
			Stock						Stock						Stock						Fair Value						Fair Value
			and RSUs						and RSUs						and RSUs (2)						Per Share						Per Share
Unvested, December 31, 2020			1,423,715						1,263,193						160,522						$	16.38					$	16.62
Granted			9,000						9,000						—						45.32						—
Vested			(40,695)						(5,765)						(34,930)						19.68						17.53
Canceled			(132,892)						(7,300)						(125,592)						15.48						16.36
Unvested, March 31, 2021 (1)			1,259,128						1,259,128						—						$	16.57					$	—

(1)Includes 43,000 RSUs which are expected to be settled in cash.

(2)Relates to the 2020 annual performance period. Total stock‑based compensation expense associated with these awards was fully recognized as of December 31, 2020.

X

- References

No definition available.

+ Details

Name:	us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration